MediPharm Labs Reports +30% Increases In Revenue, Adjusted EBITDA And Net Income In Q3
November 13, 2019 at 04:20 AM EST
During Q3 MediPharm Labs posted strong growth in revenue (+38%), adjusted EBITDA (+31%) and net income (+32%) while making significant investments in capacity and capability to benefit future performance and support global growth opportunities.
